DE3423691C1 - Arzneimittel zur Bekämpfung von Mykobakteriosen - Google Patents

Arzneimittel zur Bekämpfung von Mykobakteriosen

Info

Publication number
DE3423691C1
DE3423691C1 DE19843423691 DE3423691A DE3423691C1 DE 3423691 C1 DE3423691 C1 DE 3423691C1 DE 19843423691 DE19843423691 DE 19843423691 DE 3423691 A DE3423691 A DE 3423691A DE 3423691 C1 DE3423691 C1 DE 3423691C1
Authority
DE
Germany
Prior art keywords
mycobacterium
leprosy
methyl
component
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19843423691
Other languages
German (de)
English (en)
Inventor
Erwin Von Dr. Angerer
Wolfgang Rudolf Dr. 8400 Regensburg Meindl
Gotthard Prof. Dr. 8000 München Ruckdeschel
Helmut Prof. Dr. 8401 Pentling Schönenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DEUTSCHES AUSSAETZIGEN HILFSWE
Original Assignee
DEUTSCHES AUSSAETZIGEN HILFSWE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DEUTSCHES AUSSAETZIGEN HILFSWE filed Critical DEUTSCHES AUSSAETZIGEN HILFSWE
Priority to DE19843423691 priority Critical patent/DE3423691C1/de
Priority to IN479/MAS/85A priority patent/IN162044B/en
Application granted granted Critical
Publication of DE3423691C1 publication Critical patent/DE3423691C1/de
Priority to IN732/MAS/87A priority patent/IN166058B/en
Priority to IN512/MAS/89A priority patent/IN170047B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19843423691 1984-06-27 1984-06-27 Arzneimittel zur Bekämpfung von Mykobakteriosen Expired DE3423691C1 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE19843423691 DE3423691C1 (de) 1984-06-27 1984-06-27 Arzneimittel zur Bekämpfung von Mykobakteriosen
IN479/MAS/85A IN162044B (enrdf_load_stackoverflow) 1984-06-27 1985-06-26
IN732/MAS/87A IN166058B (enrdf_load_stackoverflow) 1984-06-27 1987-10-12
IN512/MAS/89A IN170047B (enrdf_load_stackoverflow) 1984-06-27 1989-07-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843423691 DE3423691C1 (de) 1984-06-27 1984-06-27 Arzneimittel zur Bekämpfung von Mykobakteriosen

Publications (1)

Publication Number Publication Date
DE3423691C1 true DE3423691C1 (de) 1985-12-12

Family

ID=6239281

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19843423691 Expired DE3423691C1 (de) 1984-06-27 1984-06-27 Arzneimittel zur Bekämpfung von Mykobakteriosen

Country Status (2)

Country Link
DE (1) DE3423691C1 (enrdf_load_stackoverflow)
IN (1) IN162044B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025510A1 (en) * 1994-03-18 1995-09-28 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3781443A (en) * 1971-10-26 1973-12-25 Lilly Co Eli Phenethanolamine n-methyl transferase inhibiting benzylamines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3781443A (en) * 1971-10-26 1973-12-25 Lilly Co Eli Phenethanolamine n-methyl transferase inhibiting benzylamines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Arzneimittelforschung, 22, 1972, H. 8, S. 1235-1242 *
Pharmazie, 31, 1976, H. 6, S. 374-381 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025510A1 (en) * 1994-03-18 1995-09-28 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
US5610198A (en) * 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases

Also Published As

Publication number Publication date
IN162044B (enrdf_load_stackoverflow) 1988-03-19

Similar Documents

Publication Publication Date Title
DE69304076T2 (de) N-cyano-n&#39;-pyridylguanidine als serotoninantagonisten
DE2809625A1 (de) Acetamidderivate und sie enthaltendes arzneimittel
DE2446010A1 (de) 4-(monoalkylamino)benzoesaeurederivate und verfahren zu ihrer herstellung
DE2835661C2 (enrdf_load_stackoverflow)
DE2009743A1 (de) Substituierte Biguanide mit antihyperglykämischer Wirkung
DE2012138B2 (de) N-eckige klammer auf 4-(beta-pyrazin- 2-carboxyamido-aethyl)-benzolsulphonyl eckige klammer zu -n&#39; - cycloalkylharnstoffe und diese enthaltende pharmazeutische praeparate
DE3416695A1 (de) Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3613447C2 (enrdf_load_stackoverflow)
DE2716837A1 (de) Adenin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE69223835T2 (de) Neue Aminophenolderivate und diese enthaltende pharmazeutische Zusammensetzungen
DE3423691C1 (de) Arzneimittel zur Bekämpfung von Mykobakteriosen
DE2747764A1 (de) Kombinationspraeparat und seine verwendung
DE2355262C3 (de) 1-Piperidinsulfonylharnstoffe, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2630637A1 (de) Neue sulfamylbenzylverbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
DE1963317A1 (de) Chemische Verfahren und Produkte
DE2638850A1 (de) Aralkylamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2225433A1 (de) Aminopyrazolo(3,4-b)pyridin-5-ketone mit ihren Salzen, Herstellungsverfahren dafür und Arzneimittel daraus
DE2034640A1 (de) p (Tnhalogenmethylchinolylamino) benzamide und Verfahren zu ihrer Her stellung
DE2522218A1 (de) Therapeutische zusammensetzung, methylaminderivate und verfahren zu deren herstellung
DE3808024A1 (de) 3-(2-halogenalkyl)-1,4-oxathiine und 2-(2-halogenalkyl)-1,4-dithiine und deren verwendung zur behandlung von leukaemie und tumoren
DE2757925A1 (de) Diazacyclo-1.2.4-benzothiadizine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CH579565A5 (en) Imidazolin-2-ylamino-2,1,3-benzothiadiazoles prodn. - by cyclising corresp. beta aminoethyl (thio) ureas, active against muscle tremors and rigor
DE1695284A1 (de) 2-Aminsubstituierte-4,5-Diphenyl-Oxazole mit entzuendungshemmenden Eigenschaften
EP0088323A2 (de) Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE2409791A1 (de) Derivate von 2-aminoindan, ihre herstellung und verwendung

Legal Events

Date Code Title Description
8100 Publication of the examined application without publication of unexamined application
D1 Grant (no unexamined application published) patent law 81
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee